Early research (Phase 1)Ended earlyNCT02313012What this trial is testingSafety and PK Study of CC-90003 in Relapsed/Refractory Solid TumorsWho this might be right forNeoplasm Metastasis Celgene 19
Early research (Phase 1)Ended earlyNCT02468557What this trial is testingStudy of Single Agent Idelalisib Followed by Idelalisib in Combination With Chemotherapy in Adults With Metastatic Pancreatic Ductal AdenocarcinomaWho this might be right forPreviously Untreated Pancreatic Ductal AdenocarcinomaRelapsed/Refractory Pancreatic Ductal Adenocarcinoma Gilead Sciences 16
Testing effectiveness (Phase 2)Looking for participantsNCT07410494What this trial is testingBiomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid TumorsWho this might be right forCancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more Essen Biotech 85
Early research (Phase 1)Ended earlyNCT02244489What this trial is testingMomelotinib Combined With Capecitabine and Oxaliplatin in Adults With Relapsed/Refractory Metastatic Pancreatic Ductal AdenocarcinomaWho this might be right forRelapsed/Refractory Metastatic Pancreatic Ductal Adenocarcinoma Sierra Oncology LLC - a GSK company 16
Early research (Phase 1)Looking for participantsNCT06999187What this trial is testingDR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory CarcinomasWho this might be right forTriple Negative Breast CancerHER2-negative Breast CancerNon Small Cell Lung Cancer+9 more Dren Bio 96